Pharmaceuticals, Biotechnology and Life Sciences
Bicycle is going to collaborate with ODDI, an organization with deep expertise in the molecular pathology of Alzheimer’s disease and…
Takeda got exclusive global license for investigational medicine CNP-101/TAK-101, an immune modifying nanoparticle designed to induce tolerance to gluten in…
AstraZeneca on Monday said that that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure (hHF) in adults with type-2 diabetes (T2D) and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.
Seattle Genetics’s trial of tucatinib in HER2-positive breast cancer has met primary and secondary endpoints, showing that the addition of tucatinib was superior to trastuzumab and capecitabine alone, and the company is planning NDA Submission to U.S. FDA for first quarter of 2020.
Vertex Pharmaceuticals received FDA’s approval for Trikafta (elexacaftor/tezacaftor/ivacaftor), for treating cystic fibrosis in patients older than 12, who have at…
PARSIPPANY, N.J. & JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. and its affiliates today announced a settlement agreement with both Cuyahoga and…
LONDON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that the Spanish Government has approved terms for the national reimbursement of…
CLEVELAND–(BUSINESS WIRE)–AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced this morning that they have agreed to…
BlackThorn Therapeutics has named William J. Martin, Ph.D., as Chief Executive Officer to Lead Next Stage of Growth.
Odonate Therapeutics on Monday announces completion of enrollment in CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic…